Specifications: Each tablet contains: 40 mg Telmisartan and 12.5 mg Hydrochlorothiazide
Term of Validity: 24 months
Approval Number: GYZZ H20110013
Applicable Symptoms: For the treatment of primary hypertension. The fixed-dose compound preparation of this product is used to treat patients whose blood pressure cannot be adequately controlled by telmisartan alone.
Contact Number: 4009909697
Manufacturer: Hubei Wellness Pharmaceutical Co., Ltd.
Usage and Dosage: For adult patients whose blood pressure cannot be adequately controlled by telmisartan alone, this product shall be administered once per day with drinking water, before or after meals. It is recommended to perform dose titration on the two components in the compound preparation separately before switching to using this compound preparation. If the patient condition allows, it can also be considered to directly switch from the telmisartan monotherapy to the treatment with the compound preparation. This product can be administered to patients whose blood pressure cannot be adequately controlled by telmisartan alone.
Applicable Symptoms: Indicated for heart failure caused by decreased myocardial contractility in organic heart disease, including low cardiac output syndrome after open heart surgery, as a short-term supportive therapy.
Applicable Symptoms: It is mainly indicated for severe dyspnea caused by bronchospasm. It can quickly relieve anaphylactic shock caused by drugs, and can also prolong the action time of infiltration anesthetics. It is the primary rescue drug in cardiopulmonary resuscitation for cardiac arrest caused by various reasons.
Applicable Symptoms: 1. It can help increasing blood pressure to treat hypotension during general anesthesia and prevent arrhythmia; and it can also be used to treat hypotension induced by intraspinal block, but with the possibility of reducing cardiac output. 2. It can be used to terminate the onset of paroxysmal supraventricular tachycardia.
Applicable Symptoms: Indicated for shock syndrome caused by myocardial infarction, trauma, endotoxin sepsis, cardiac surgery, renal failure, and congestive heart failure; and for shock events that cannot be rescued by blood volume supplementation, especially for those with oliguria and normal or low peripheral vascular resistance. Since this product can increase cardiac blood output, it is also used for cardiac insufficiency where foxglove and diuretics are ineffective.
Applicable Symptoms: It is mainly indicated for severe dyspnea caused by bronchospasm. It can quickly relieve anaphylactic shock caused by drugs, and can also prolong the action time of infiltration anesthetics. It is the primary rescue drug in cardiopulmonary resuscitation for cardiac arrest caused by various reasons.
Applicable Symptoms: Indicated for blood pressure control in certain acute hypotensive situations (e.g., pheochromocytoma resection, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, sepsis, blood transfusion, and drug adverse reactions). Used as an adjuvant therapy for cardiac arrest and severe hypotension. For the emergency treatment of hypovolemia-induced shock, this product can be used as an adjuvant therapy to achieve blood volume supplementation, so as to help increase blood pressure and temporarily maintain perfusion in cerebral and coronary arteries until the blood volume supplementation takes effect; it can also be used for maintaining blood pressure after cardiopulmonary resuscitation (CPR).
